Naloxone must be dispensed and billed to anyone who requests it, regardless of who will be administered the medication. This line supports inquiries from clinicians only (MD, NP, PA, RN, PharmD or DDS) and is not intended for patient or consumer questions. Programs should consider having staff attend a train‐the‐trainer session, such as one offered by the  Harm Reduction Coalition. The Health Department will return an authorized standing order for your pharmacy within 10 business days. Under Public Health Law Section 3309: “the purchase, acquisition, possession or use of an opioid antagonist pursuant to this section shall not constitute the unlawful practice of a profession or other violation under title eight of the education law or this article.” In addition: "Use of an opioid antagonist pursuant to this section shall be considered first aid or emergency treatment for the purpose of any statute relating to liability.". The designation of individuals to dispense or furnish naloxone is sometimes referred to as a “standing order” though in New York State, consistent with Public Health Law Section 3309, it is known as a "non‐patient specific prescription." For some trainings, abbreviated training that only covers the core elements of overdose recognition and response may be appropriate. opioid overdose prevention training curriculum offered by an authorized opioid overdose prevention program and has been authorized by a registered provider to possess the opioid antagonist; (ii) is a public safety officer who has completed a curriculum approved by the division of criminal justice services for purposes of intervening in opioid overdoses prior to the arrival of emergency medical services; or, (iii) is a firefighter who has completed a comparable curriculum approved by the department.”. Trainers of public safety personnel should either be General Topics Instructors certified by the Division of Criminal Justice Services (DCJS) or Special Topics Instructors specifically certified by DCJS to provide opioid overdose training. Please see detailed information on reporting below. The program director or the clinical director may assume the training role. The Department of Health interprets the liability protection provided by Public Health Law §3309 (4) as being inclusive of clinical directors and affiliated prescribers of registered opioid overdose prevention programs, so long as they are acting reasonably and in good faith. (v) identification of the group of trained overdose responders who may have access to the naloxone under the prescription, where applicable. Flexibility is encouraged in the both the content of the curriculum and in its delivery. Program directors have the overall responsibility for managing their programs and for being the primary liaison with the Department. There are currently four naloxone products available: Billing Email questions or concerns related to naloxone to pharmacynaloxone@health.nyc.gov. This is one collaborative practice model. Although all resuscitation techniques can be valuable and should be given serious consideration for incorporation in a program’s curriculum, they are not required elements. Naloxone may be dispensed or furnished in the following ways: Do prescribers always need to be present when naloxone is furnished to trained overdose responders? To be able to bill under N-CAP, the pharmacy must be enrolled in the New York State AIDS Drug Assistance Program (ADAP). The statute contains this provision: "A recipient or opioid overdose prevention program under this section, acting reasonably and in good faith in compliance with this section, shall not be subject to criminal, civil or administrative liability solely by reason of such action."